← Back to Clinical Trials
Recruiting NCT07383753

NCT07383753 Virtual Hand-Arm Assessments for Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07383753
Status Recruiting
Phase
Sponsor Holland Bloorview Kids Rehabilitation Hospital
Condition Cerebral Palsy (CP)
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-10-22
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
Upper-Limb Virtual and In-Person Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-10-22 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cerebral palsy (CP) affects approximately 1 in 500 Canadian children, and the majority experience hand and arm limitations that impact independence, participation in daily activities, and overall quality of life. Many children require ongoing clinical assessments and therapy delivered in specialized centres, creating significant burden related to travel, scheduling, and interruptions to school and work. Barriers such as geography, socioeconomic factors, and pandemic-related service disruptions have further limited equitable access to in-person care. Although virtual care has expanded rapidly and families have expressed strong interest in hybrid care models, there is currently no validated approach for conducting comprehensive virtual hand-arm assessments for children with CP. Virtual administration of standardized assessments, individualized goal-based evaluations, and naturalistic observation tools has not been systematically studied. Evidence is urgently needed to determine which assessments can be administered virtually, how acceptable and feasible they are for families, and whether virtual and in-person assessment methods produce equivalent results.

Eligibility Criteria

Inclusion Criteria: * Have a diagnosis of Cerebral Palsy * Are between 6 to 17 years old with sufficient cognitive capacity and cooperation to sit without a break for 30 minutes at a time * MACS levels I (handles objects easily) to III (handles objects with difficulty) * No visual limitations that would interfere with video conferencing * Has a caregiver willing to participate and can questions about preferences * Have an appropriate device and internet access for video conferencing Exclusion Criteria: \- Active treatments (e.g. Botulinum Toxin injections or constraint therapy in the last two months, or upper extremity surgery in the last 6 months) that might impact upper limb function stability over the study period.

Contact & Investigator

Central Contact

Selvi Sert, MEng

✉ ssert@hollandbloorview.ca

📞 416-425-6220

Principal Investigator

Elaine Biddiss, PhD

PRINCIPAL INVESTIGATOR

Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute

Frequently Asked Questions

Who can join the NCT07383753 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07383753 currently recruiting?

Yes, NCT07383753 is actively recruiting participants. Contact the research team at ssert@hollandbloorview.ca for enrollment information.

Where is the NCT07383753 trial being conducted?

This trial is being conducted at Ajax, Canada, Ottawa, Canada, Toronto, Canada.

Who is sponsoring the NCT07383753 clinical trial?

NCT07383753 is sponsored by Holland Bloorview Kids Rehabilitation Hospital. The principal investigator is Elaine Biddiss, PhD at Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology